Transjugular intrahepatic portosystemic shunt in refractory ascites: A meta-analysis

Liver International

Volumn 25, Issue 2, 2005, Pages 349-356

  Deltenre, P ^a,b   Mathurin, Philippe ^a   Dharancy, S ^a   Moreau, R ^c   Bulois, P ^a   Henrion, J ^b   Pruvot, F R ^a   Ernst, O ^a   Paris, J C ^a   Lebrec, D ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Hospital de Jolimont   (Belgium)

^c BEAUJON HOSPITAL   (France)

Author keywords

Meta analysis; Portal hypertension; Randomized controlled trials; Refractory ascites; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ARTICLE; ASCITES; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE CONTROL; FREQUENCY ANALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PARACENTESIS; PORTOSYSTEMIC ANASTOMOSIS; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

AGED; ASCITES; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 20144386611     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01095.x     Document Type: Article

References (88)

1. Arroyo V, Gines P, Gerbes A L, Dudley F J, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Int Ascites Club Hepatol 1996; 23: 164-76.
2. Franco D, Vons C, Traynor O, de Smadja C. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Arch Surg 1988; 123: 987-91.
3. Somberg K A, Lake J R, Tomlanovich S J, LaBerge J M, Feldstein V, Bass N M. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21: 709-16.
4. Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villarreal L, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995; 21: 986-94.
5. Williams D B, Waugh R, Selby W. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites. Aust NZ J Med 1998; 28: 620-6.
6. Deschenes M, Dufresne M P, Bui B, Fenyves D, Spahr L, Roy L, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999; 94: 1361-5.
7. Michl P, Gulberg V, Bilzer M, Waggershauser T, Reiser M, Gerbes A L. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scand J Gastroenterol 2000; 35: 654-8.
8. Peron J M, Barange K, Otal P, Rousseau H, Payen J L, Pascal J P, et al. Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: results in 48 consecutive patients. J Vasc Interv Radiol 2000; 11: 1211-6.
9. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996; 25: 135-44.
10. Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701-7.
11. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath P S, Del Arbol L R, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839-47.
12. Salerno F, Merli M, Cazzaniga M, Riggio O, Valeriano V, Nicolini A, et al. Randomized controlled study of TIPS vs. paracentesis with albumin in cirrhosis with refractory ascites. Hepatology 2002; 36: 318A.
13. Sanyal A J, Genning C, Reddy K R, Wong F, Kowdley K V, Benner K, et al. The North American Study for the treatment of refractory ascites. Gastroenterology 2003; 124: 634-41.
14. Ochs A, Rossle M, Haag K, Hauenstein K H, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-7.
15. Bosch J, Garcia-Pagan J C. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32: 141-56.
16. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122: 816-22.
17. Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40: 629-35.
18. Poynard T, Conn H O. The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods. Control Clin Trials 1985; 6: 271-9.
19. Demets D L. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987; 6: 341-50.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
21. Cochran W G. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
22. Hausegger K A, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol 2004; 15: 239-48.
23. Ter Borg P C, Hollemans M, Van Buuren H R, Vleggaar F P, Groeneweg M, Hop W C, et al. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years. Radiology 2004; 231: 537-45.
24. Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, et al. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 2003; 50: 1753-5.
25. Wong F, Sniderman K, Liu P, Blendis L. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997; 112: 899-907.
26. Wong W, Liu P, Blendis L, Wong F. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites. Am J Med 1999; 106: 315-22.
27. Cejna M, Thurnher S, Pidlich J, Kaserer K, Schoder M, Lammer J. Primary implantation of polyester-covered stent-grafts for transjugular intrahepatic portosystemic stent shunts (TIPSS): a pilot study. Cardiovasc Intervent Radiol 1999; 22: 305-10.
28. Cejna M, Peck-Radosavljevic M, Thurnher S A, Hittmair K, Schoder M, Lammer J. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis. Radiology 2001; 221: 437-46.
29. Gulberg V, Liss I, Bilzer M, Waggershauser T, Reiser M, Gerbes A L. Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts. Digestion 2002; 66: 127-30.
30. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52: 879-85.
31. Ferral H, Bjarnason H, Wegryn S A, Rengel G J, Nazarian K, Rank J M, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189: 795-801.
32. Ferral H, Gamboa P, Postoak D W, Albernaz V S, Young C R, Speeg K V, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004; 231: 231-6.
33. Walser E, Ozkan O S, Raza S, Soloway R, Gajula L. Hepatic perfusion as a predictor of mortality after transjugular intrahepatic portosystemic shunt creation in patients with refractory ascites. J Vasc Interv Radiol 2003; 14: 1251-7.
34. Rousseau H, Vinel J P, Bilbao J I, Longo J M, Maquin P, Zozaya J M, et al. Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: a follow-up study. Cardiovasc Intervent Radiol 1994; 17: 7-11.
35. Forster J, Delcore R, Payne K M, Siegel E L. The role of transjugular intrahepatic portosystemic shunts in the management of patients with end-stage liver disease. Am J Surg 1994; 168: 592-6.
36. Lafortune M, Martinet J P, Denys A, Patriquin H, Dauzat M, Dufresne M P, et al. Short-and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. Am J Roentgenol 1995; 164: 997-1002.
37. Spiess S E, Matalon T A, Jensen D M, Rosenblate H J, Brunner M C, Ganger D R. Transjugular intrahepatic portosystemic shunt in nonliver transplant candidates: is it indicated? Am J Gastroenterol 1995; 90: 1238-43.
38. Meyer K M, Zibari G B, McMillan R W, Vickers B, Gholson C, Marsala A, et al. A retrospective study of the efficacy of transjugular intrahepatic portosystemic shunts. Am Surg 1996; 62: 76-80.
39. Rossi P, Bezzi M, Salvatori F M, Broglia L, Maccioni F, Pizzi G, et al. Self-expanding stents in transjugular intrahepatic portosystemic shunt: experience with nitinol Strecker stents. Eur Radiol 1996; 6: 741-7.
40. Cosenza C A, Hoffman A L, Friedman M L, Sher L S, Lopez R R, Van Allen R, et al. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation. Am Surg 1996; 62: 835-9.
41. Forrest E H, Stanley A J, Redhead D N, McGilchrist A J, Hayes P C. Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther 1996; 10: 801-6.
42. Kimura M, Sato M, Kawai N, Tanaka K, Sonomura T, Kishi K, et al. Efficacy of Doppler ultrasonography for assessment of transjugular intrahepatic portosystemic shunt patency. Cardiovasc Intervent Radiol 1996; 19: 397-400.
43. Martinet J P, Fenyves D, Legault L, Roy L, Dufresne M P, Spahr L, et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution. Dig Dis Sci 1997; 42: 161-6.
44. Nazarian G K, Bjarnason H, Dietz C A Jr., Bernadas C A, Foshager M C, Ferral H, et al. Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997; 205: 173-80.
45. Rees C J, Rose J D, Record C O, Day C P, Bassendine M F, James O F, et al. Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites. Eur J Gastroenterol Hepatol 1997; 9: 969-73.
46. Urata J, Yamashita Y, Hatanaka Y, Sumi S, Matsuno Y, Tsuchigame T, et al. Transjugular intrahepatic portosystemic shunt: initial clinical experience and three-year follow-up. Radiat Med 1997; 15: 341-51.
47. Trotter J F, Suhocki P V, Rockey D C. Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score. Am J Gastroenterol 1998; 93: 1891-4.
48. Gerbes A L, Gulberg V, Waggershauser T, Holl J, Reiser M. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 1998; 28: 683-8.
49. Denie C, Vachiery F, Gadano A, Sogni P, Elman A, Moreau R, et al. Influence of transjugular intrahepatic portosystemic shunts (TIPS) on tissue oxygenation in patients with cirrhosis. Liver 1998; 18: 239-44.
50. Stanley A J, Redhead D N, Bouchier I A, Hayes P C. Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis. Am J Gastroenterol 1998; 93: 2463-8.
51. Ugolotti U, Larini P, Marcato C, Saccani A, Pedretti G. TIPS (transjugular intrahepatic portosystemic shunt): state of art and personal experience. Acta Biomed Ateneo Parmense 1996; 67: 143-9.
52. Chalasani N, Clark W S, Martin L G, Kamean J, Khan M A, Patel N H, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118: 138-44.
53. Nolte W, Ehrenreich H, Wiltfang J, Pahl K, Unterberg K, Kamrowski-Kruck H, et al. Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS). Liver 2000; 20: 60-5.
54. Schiano T D, Black M, Hills C, Ter H, Bellary S, Miller L S. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt. South Med J 2000; 93: 305-9.
55. Hidajat N, Vogl T, Stobbe H, Schmidt J, Wex C, Lenzen R, et al. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center. Acta Radiol 2000; 41: 474-8.
56. Thuluvath P J, Bal J S, Mitchell S, Lund G, Venbrux A. TIPS for management of refractory ascites: response and survival are both unpredictable. Dig Dis Sci 2003; 48: 542-50.
57. Allard J P, Chau J, Sandokji K, Blendis L M, Wong F. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 2001; 96: 2442-7.
58. Domagk D, Patch D, Dick R, Grosso M, Rousseau H, Otal P, et al. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study. Cardiovasc Intervent Radiol 2002; 25: 506-12.
59. Singh R, Nair S. Tips in refractory ascites: correlation between portosystemic gradient and response. Gastroenterology 2002; 122(Suppl. 1): A353.
60. Haskal Z J. Interim U.S. multicenter results of viatorr EPTFE TIPS endoprosthesis trial. Hepatology 2003; 38: 293A.
61. Therapondos G, De Jong W, Snideman K, Blendis L, Wong F. The effect of transjugular intrahepatic portosystemic stent shunt (TIPS) on cardiac function and structure in cirrhotic patients with refractory ascites. J Hepatol 2004; 40(Suppl. 1): 65.
62. Bresky G, Fernandez J, Navasa M, Garcia-Pagan J C. Bacterial infections in cirrhotic patients with transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 63(Suppl. 1): 201.
63. Rossi P, Salvatori F M, Fanelli F, Bezzi M, Rossi M, Marcelli G, et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology 2004; 231: 820-30.
64. van Buuren H R, ter Borg P C. Transjugular intrahepatic portosystemic shunt (TIPS): indications and long-term patency. Scand J Gastroenterol 2003; 38(Suppl. 239): 100-4.
65. Cohnen M, Luthen R, Daubener W, Modder U. Lack of portosystemic bacterial translocation in patients with liver cirrhosis after placement of transjugular shunt. Eur J Clin Microbiol Infect Dis 2003; 22: 310-2.
66. Madoff D C, Perez-Young I V, Wallace M J, Skolkin M D, Toombs B D. Management of TIPS-related refractory hepatic encephalopathy with reduced wallgraft endoprostheses. J Vasc Interv Radiol 2003; 14: 369-74.
67. Zhuang Z W, Teng G J, Jeffery R F, Gemery J M, Janne d'Othee B, Bettmann M A. Long-term results and quality of life in patients treated with transjugular intrahepatic portosystemic shunts. Am J Roentgenol 2002; 179: 1597-603.
68. Russo M W, Jacques P F, Mauro M, Odell P, Brown R S Jr. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Liver Transplant 2002; 8: 271-7.
69. Otal P, Smayra T, Bureau C, Peron J M, Chabbert V, Chemla P, et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. Am J Roentgenol 2002; 178: 141-7.
70. Malinchoc M, Kamath P S, Gordon F D, Peine C J, Rank J, ter Borg P C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
71. Latimer J, Bawa S M, Rees C J, Hudson M, Rose J D. Patency and reintervention rates during routine TIPSS surveillance. Cardiovasc Intervent Radiol 1998; 21: 234-9.
72. Jalan R, Redhead D N, Thomas H W, Henderson N, O'Rourke K, Dillon J F, et al. Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 1996; 8: 1111-6.
73. Martinet J P, Legault L, Cernacek P, Roy L, Dufresne M P, Spahr L, et al. Changes in plasma endothelin-1 and big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 1996; 25: 700-6.
74. Van der Linden P, Le Moine O, Ghysels M, Ortinez M, Deviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 1996; 23: 982-7.
75. Sanyal A J, Freedman A M, Purdum P P, Shiffman M L, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996; 23: 32-9.
76. Kerlan R K Jr., LaBerge J M, Baker E L, Wack J P, Marx M, Somberg K A, et al. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1995; 6: 917-21.
77. Crenshaw W B, Gordon F D, McEniff N, Perry L J, Hartnell G, Anastopoulos H, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996; 200: 185-92.
78. Russo M W, Sood A, Jacobson I M, Brown R S Jr. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol 2003; 98: 2521-7.
79. Bureau C, Garcia Pagan J C, Pomier Layrargues G, Otal P, Chabbert V, Cortez C, et al. The use of polytetrafluoroethylene (PTFE) covered stents improves the patency of TIPS: results of a randomized study. Hepatology 2002; 36: 294A.
80. Bureau C, Garcia-Pagan J C, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126: 469-75.
81. Masini A, Efrati C, Nicolao F, Merli M, Attili A F, Riggio O. Randomized controlled trial for the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS): comparison between lactitol, rifaximin and no treatment. J Hepatol 2004; 40(Suppl. 1): 70-1.
82. Amesur N B, Zajko A B, Orons P D, Sammon J K, Casavilla F A. Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation. J Vasc Interv Radiol 1999; 10: 569-73.
83. Lerut J P, Goffette P, Molle G, Roggen F M, Puttemans T, Brenard R, et al. Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation 1999; 68: 379-84.
84. Abouljoud M S, Yoshida A, Moonka D, Croteau D, McVinnie D, Sharma R, et al. Favorable outcomes after selective use of transjugular intrahepatic portosystemic shunts following liver transplantation. Hepatology 2003; 38: 377A.
85. Sanyal A J, Genning C, Reddy R K, Wong F, Kowdley K, Benner K, et al. The North American Study of Treatment for Refractory Ascites (NASTRA). Gastroenterology 2002; 122(Suppl. 1): 643.
86. Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 93: 234-41.
87. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 1493-502.
88. Garcia-Tsao G. Treatment of refractory ascites: tips or taps? Hepatology 2001; 33: 477-9.